Great Point Partners’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q1 | – | Sell |
-21,322
| Closed | -$392K | – | 35 |
|
2014
Q4 | $392K | Buy |
+21,322
| New | +$392K | 0.19% | 27 |
|
2014
Q3 | – | Sell |
-16,779
| Closed | -$612K | – | 41 |
|
2014
Q2 | $612K | Sell |
16,779
-74,437
| -82% | -$2.72M | 0.27% | 35 |
|
2014
Q1 | $4.18M | Sell |
91,216
-8,784
| -9% | -$402K | 2.18% | 19 |
|
2013
Q4 | $3.89M | Buy |
100,000
+60,099
| +151% | +$2.34M | 2.75% | 18 |
|
2013
Q3 | $1.81M | Buy |
+39,901
| New | +$1.81M | 1.25% | 21 |
|